Clinical studies in prostate cancer demonstrated that overexpression of colony-stimulating factor (CSF-1) and its receptor (CSF1R or c-FMS), were responsible for monocyte and macrophage expansion, indicating poor prognosis in primary prostate cancers and development of bone metastasis [9]. Here, CSF2 is linked to prostate carcinoma.